First Capital Advisors Group, Llc. Merck & Co., Inc. Transaction History

First Capital Advisors Group, Llc.

$188 Million
Q2 2023

A detailed history of First Capital Advisors Group, Llc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 9,146 shares of MRK stock, worth $899,417. This represents 0.56% of its overall portfolio holdings.

Number of Shares

9,146

Previous 9,154 0.09%

Holding current value

$899,417

Previous $973,000 8.43%

% of portfolio

0.56%

Previous 0.63%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$108.61 - $118.38 $868 - $947	-8 Reduced 0.09%	9,146 $1.06 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $22,749 - $25,384	-221 Reduced 2.36%	9,154 $973,000
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $68,028 - $87,221	-778 Reduced 7.66%	9,375 $1.04 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $40,236 - $45,200	476 Added 4.92%	10,153 $874,000
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $807,932 - $915,831	9,677 New	9,677 $882,000
Q4 2021 Mar 02, 2022	SELL	$72.28 - $90.54 $769,203 - $963,526	-10,642 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$65.24 - $75.71 $78,875 - $91,533	-1,209 Reduced 10.2%	10,642 $813,000
Q3 2018 Oct 24, 2018	SELL	$57.69 - $67.84 $807 - $949	-14 Reduced 0.12%	11,851 $841,000
Q2 2018 Jul 30, 2018	BUY	$50.83 - $59.72 $160,622 - $188,715	3,160 Added 36.3%	11,865 $720,000
Q1 2018 Apr 11, 2018	SELL	$50.96 - $59.23 $52,284 - $60,769	-1,026 Reduced 10.54%	8,705 $474,000
Q4 2017 Jan 25, 2018	SELL	$51.62 - $61.64 $48,574 - $58,003	-941 Reduced 8.82%	9,731 $0
Q3 2017 Oct 31, 2017	BUY	$58.67 - $63.13 $626,126 - $673,723	10,672	10,672 $683,000

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Capital Advisors Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on First Capital Advisors Group, Llc. with notifications on news.

Account

First Capital Advisors Group, Llc. Merck & Co., Inc. Transaction History